V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007494 | 240013520 | 1.67 | 81.7 | Palliative (P) | 2013-07-13 | 2013-07-13 | Carboplatin + Etoposide iv&po | 02 | N | 240033711 | CARBOPLATIN + ETOPOSIDE |
| 240007495 | 240013520 | 1.51 | 56.5 | Curative (C) | 2014-09-22 | 2014-09-27 | INTERLACE TRIAL | N | N | 240033711 | INTERLACE TRIAL |
| 240007496 | 240013520 | 1.68 | 78 | Palliative (P) | 2016-10-22 | 2016-10-23 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240033711 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007497 | 240004655 | 1.65 | 62.2 | Palliative (P) | 2016-10-23 | 2016-10-23 | Bevacizumab+Carbo+Pacliaxel | N | N | 240033724 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007498 | 240004656 | 1.64 | 56 | Curative (C) | 2017-03-06 | 2017-03-06 | SMILE | 02 | N | 240033726 | TRIAL |
| 240007499 | 240004657 | 0 | null | Curative (C) | 2018-01-08 | 2018-02-09 | Carboplatin AUC 6 - 10 | 02 | N | 240033730 | CARBOPLATIN |
| 240007500 | 240010593 | null | 50.8 | Neo-adjuvant (N) | 2016-09-07 | 2016-09-07 | INTERLACE TRIAL | N | N | 240033733 | INTERLACE TRIAL |
| 240007501 | 240004658 | 1.82 | 100.3 | Disease modification (D) | 2019-02-12 | 2019-02-22 | Chlorambucil | N | N | 240033739 | CHLORAMBUCIL |
| 240007502 | 240004659 | null | 81.5 | Curative (C) | 2015-03-22 | 2015-03-24 | R Chlorambucil | 02 | N | 240033743 | CHLORAMBUCIL + RITUXIMAB |
| 240007503 | 240004659 | 1.63 | 119.2 | Curative (C) | 2014-10-18 | 2014-10-18 | Bendamustine +/- Prednisolone | N | N | 240033743 | BENDAMUSTINE |
| 240007504 | 240004660 | 1.53 | 104.7 | Curative (C) | null | 2013-02-11 | Bendamustine +/- Prednisolone | 02 | N | 240033750 | BENDAMUSTINE |
| 240007505 | 240004661 | 1.41 | 88 | Curative (C) | 2017-08-17 | 2017-08-18 | Chlorambucil | Y | N | 240033751 | CHLORAMBUCIL |
| 240007506 | 240004662 | 1.62 | 75.4 | Curative (C) | null | 2018-01-29 | Carboplatin AUC 6 - 10 | N | N | 240033754 | CARBOPLATIN |
| 240007507 | 240004663 | 1.58 | 76.4 | Palliative (P) | 2016-09-01 | 2016-09-10 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240033758 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007508 | 240004663 | 1.65 | 0 | Palliative (P) | 2016-08-29 | 2016-09-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240033758 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007509 | 240004664 | 1.72 | 91.6 | Curative (C) | 2016-05-06 | 2016-05-06 | INTERLACE TRIAL | 2 | N | 240033762 | INTERLACE TRIAL |
| 240007510 | 240004665 | 1.66 | 58.9 | Curative (C) | 2013-03-05 | 2013-03-05 | null | N | N | 240033765 | NOT MATCHED |
| 240007511 | 240004665 | null | 78.1 | Curative (C) | 2015-05-14 | 2015-05-21 | DA 3 + 10 | 1 | Y | 240033765 | DA |
| 240007512 | 240004665 | 1.61 | 93 | Curative (C) | 2014-05-07 | 2014-05-28 | Carboplatin AUC 6 - 10 | N | N | 240033765 | CARBOPLATIN |
| 240007513 | 240004665 | 1.58 | 49.9 | null | 2015-01-02 | 2015-01-10 | R Chlorambucil | N | N | 240033765 | CHLORAMBUCIL + RITUXIMAB |
| 240007514 | 240004666 | 1.75 | 0 | Palliative (P) | 2016-04-17 | 2016-04-17 | Chlorambucil | 02 | null | 240033779 | CHLORAMBUCIL |
| 240007515 | 240004666 | 0 | 66.8 | Palliative (P) | 2018-09-15 | 2018-09-15 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240033779 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007516 | 240004667 | null | null | Palliative (P) | 2016-05-24 | 2016-06-06 | Chlorambucil | null | null | 240033782 | CHLORAMBUCIL |
| 240007517 | 240004668 | null | null | Palliative (P) | 2017-10-10 | 2017-10-21 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | null | 240033790 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007518 | 240010598 | 1.71 | null | Palliative (P) | 2016-01-27 | 2016-01-28 | Carboplatin + Etoposide iv&po | null | null | 240033803 | CARBOPLATIN + ETOPOSIDE |
| 240007519 | 240010598 | 1.66 | 66 | Palliative (P) | 2013-05-03 | 2013-06-02 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 240033803 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007520 | 240010598 | 1.53 | 54.8 | Palliative (P) | 2017-08-13 | 2017-08-14 | Chlorambucil | N | N | 240033803 | CHLORAMBUCIL |
| 240007521 | 240004669 | 1.82 | 0 | Palliative (P) | 2014-08-04 | 2014-08-16 | Carboplatin + Etoposide IV 3 day | N | N | 240033811 | CARBOPLATIN + ETOPOSIDE |
| 240007522 | 240004670 | 1.7 | 78.8 | null | 2017-07-07 | 2017-07-07 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240033817 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007523 | 240004671 | null | 0 | null | 2016-04-14 | 2016-06-21 | DA 3 + 10 | N | N | 240033826 | DA |
| 240007524 | 240004672 | 1.75 | 34 | Palliative (P) | 2018-01-07 | 2018-01-07 | Bevacizumab + CARBOPLATIN + PACLITAXEL | Y | N | 240033827 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007525 | 240010599 | 1.74 | 34 | Palliative (P) | 2013-03-20 | 2013-03-28 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 240033830 | CHLORAMBUCIL + RITUXIMAB |
| 240007526 | 240004673 | 1.64 | 145 | Palliative (P) | 2015-01-28 | 2015-02-19 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240033833 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007527 | 240010600 | 0 | 79.6 | Curative (C) | null | 2014-08-01 | CHLORAMBUCIL + RITUXIMAB | 01 | N | 240033835 | CHLORAMBUCIL + RITUXIMAB |
| 240007528 | 240004674 | 1.75 | 89 | null | null | 2017-07-28 | R Chlorambucil | N | N | 240033840 | CHLORAMBUCIL + RITUXIMAB |
| 240007529 | 240004674 | 1.68 | 77.1 | Neo-adjuvant (N) | 2014-10-03 | 2014-10-09 | INTERLACE TRIAL | N | null | 240033840 | INTERLACE TRIAL |
| 240007530 | 240004675 | 0 | null | Palliative (P) | null | 2014-07-21 | R Chlorambucil | N | N | 240033851 | CHLORAMBUCIL + RITUXIMAB |
| 240007531 | 240004676 | 1.81 | 29.9 | null | 2016-01-18 | 2016-01-30 | DA 3 + 10 | N | N | 240033852 | DA |
| 240007532 | 240010602 | 1.64 | 83.7 | Curative (C) | 2013-08-20 | 2013-09-16 | Carboplatin AUC 6 - 10 | N | N | 240033853 | CARBOPLATIN |
| 240007533 | 240010602 | 1.58 | null | Palliative (P) | 2016-07-04 | 2016-07-26 | R Chlorambucil | 02 | N | 240033853 | CHLORAMBUCIL + RITUXIMAB |
| 240007534 | 240010602 | 1.7 | 59.6 | Curative (C) | 2016-01-20 | 2016-01-30 | INTERLACE TRIAL | 2 | N | 240033853 | INTERLACE TRIAL |
| 240007535 | 240004677 | 166 | 71.1 | Palliative (P) | 2017-03-26 | 2017-04-01 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240033862 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007536 | 240004678 | 1.85 | 96.5 | Palliative (P) | null | 2015-12-15 | Bortezomib + CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 240033863 | NOT MATCHED |
| 240007537 | 240004678 | 1.56 | null | Disease modification (D) | 2014-10-31 | 2014-10-31 | R Chlorambucil | 2 | null | 240033863 | CHLORAMBUCIL + RITUXIMAB |
| 240007538 | 240004679 | 1.73 | null | Curative (C) | 2017-10-07 | 2017-10-14 | SMILE | null | null | 240033865 | TRIAL |
| 240007539 | 240004680 | 1.65 | 67 | Neo-adjuvant (N) | 2013-09-25 | 2013-10-11 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240033866 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007540 | 240004681 | 1.7 | 47.7 | Curative (C) | 2016-03-29 | 2016-04-23 | INTERLACE TRIAL | null | null | 240033867 | INTERLACE TRIAL |
| 240007541 | 240004681 | 1.62 | 70 | Curative (C) | 2013-05-19 | 2013-05-31 | BENDAMUSTINE | 02 | N | 240033867 | BENDAMUSTINE |
| 240007542 | 240004682 | null | null | null | 2017-11-07 | 2017-11-30 | R Chlorambucil | 02 | null | 240033884 | CHLORAMBUCIL + RITUXIMAB |
| 240007543 | 240004682 | 1.68 | 68.9 | Disease modification (D) | 2016-04-24 | 2016-05-05 | Bendamustine + prednisolone | 02 | N | 240033884 | BENDAMUSTINE |